Used in pharmaceutical research as a key intermediate in the synthesis of targeted cancer therapies, particularly kinase inhibitors. Its structure enables selective binding to specific enzyme sites involved in tumor growth signaling pathways.

Commonly employed in the development of antitumor agents due to its ability to mimic nucleoside motifs, facilitating interference with DNA repair mechanisms in cancer cells.

Also utilized in PROTAC (proteolysis-targeting chimera) design to promote degradation of disease-causing proteins. Valued for its stability and reactivity in conjugation reactions, making it suitable for bioconjugation and labeling strategies in drug discovery.